Resumen
La prevalencia de dolor en pacientes de Clínica Colsanitas es importante y se encuentra dentro de lo reportado internacionalmente. Dentro de las estrategias para disminuir el dolor y mejorar la atención de los pacientes se encuentra la Política de hospital sin dolor y protocolos de manejo de dolor en situaciones específicas. El presente artículo resume las directrices del protocolo de manejo analgésico de pacientes con dolor agudo (diferente al dolor postoperatorio y al dolor crónico) durante su estancia hospitalaria, con el propósito de promover el uso seguro de los analgésicos y aportar al valor corporativo de la compasión.
Citas
Sawyer J, Haslam L, Daines P, Stilos K. Pain prevalence study in a large Canadian teaching hospital. Round
: lessons learned? Pain Manag Nurs. 2010 Mar;11(1):45-55. 2. Fabbian F, De Giorgi A, Pala M, Mallozzi Menegatti A, Gallerani M, Manfredini R. Pain prevalence and management in an internal medicine setting in Italy. Pain Res Treat. 2014;2014:628284. https://doi.org/10.1155/2014/628284
Bolíbar I, Català E, Cadena R. Pain in the hospital: from prevalence to quality standards. Rev Esp Anestesiol Reanim. 2005 Mar;52(3):131-40.
Echevarria M, Ortega J, Herrera J, Galvez R, Torres L, de la Torre Liebanas R. Prevalence of pain in Andalusian public hospitals. Rev Esp Anestesiol Reanim. 2014;61(10):549-56. https://doi.org/10.1016/j.redar.2014.03.004
Erazo M, Pérez L, Colmenares C, Álvarez H, Suárez I, Mendivelso F. Prevalencia y caracterización del dolor en pacientes hospitalizados. Rev. Soc. Esp. Dolor. 2015;22(6):241-48. https://doi.org/10.4321/S1134-80462015000600005
Organización Mundial de la Salud. Directrices de la OMS sobre el tratamiento farmacológico del dolor persistente en niños con enfermedades médicas [Internet]. Organización Mundial de la Salud. 2012. [Consultado 28 de febrero 2018] Disponible en: http://www.who.int/medicines/areas/quality_safety/3PedPainGLs_coverspanish.pdf
Loeser JD, Treede RD. The Kyoto protocol of IASP Basic Pain Terminology. Pain. 2008;137(3):473-7. https://doi.org/10.1016/j.pain.2008.04.025
Stevens B, Johnston C, Petryshen P, Taddio A. Premature Infant Pain Profile: development and initial validation. Clin J Pain. 1996 Mar;12(1):13-22. https://doi.org/10.1097/00002508-199603000-00004
Pardo C, Muñoz T, Chamorro C. Monitorización del dolor: Recomendaciones del grupo de trabajo de analgesia y sedación de la SEMICYUC. Med. Intensiva. 2006;30(8):379-385. https://doi.org/10.1016/S0210-5691(06)74552-1
Hauer J, Duncan J, Scullion B. Pediatric pain and symptom management guidelines. Dana Farber Cancer Institute/Boston Children's Hospital. Pediatric Advanced Care Team. [Internet] 2014. [Consultado 28 de febrero 2018] Disponible en: http://www.virtualhospice.ca/Assets/Boston%20Pediatric%20Pain%20&%20Symptom%20Management%20Guidelines%20-%202014_20170104132605.pdf
Krauss BS, Calligaris L, Green SM, Barbi E. Current concepts in management of pain in children in the emergency department. Lancet.2016;387(10013):83-92. https://doi.org/10.1016/S0140-6736(14)61686-X
Furyk J, Levas D, Close B, Laspina K, Fitzpatrick M, Robinson K, Vangaveti VN, Ray R. Intravenous versus oral paracetamol for acute pain in adults in the emergency department setting: a prospective, double-blind, double-dummy, randomised controlled trial. Emerg Med J. 2018 Mar;35(3):179-184.https://doi.org/10.1136/emermed-2017-206787
Babl FE, Theophilos T, Palmer GM. Is there a role for intravenous acetaminophen in pediatric emergency departments? Pediatr Emerg Care.2011;27(6):496-9.https://doi.org/10.1097/PEC.0b013e31821d8629
Shastri N. Intravenous acetaminophen use in pediatrics. Pediatr Emerg Care. 2015;31(6):444-8; quiz 449-50. https://doi.org/10.1097/PEC.0000000000000463
Agencia Española de Medicamentos. Paracetamol de administración intravenosa. [Internet] Agencia Española de Medicamentos y Productos Sanitarios. Obtenido de Notas Informativas. 2012 [Consultado 28 de febrero 2018] Disponible en: https://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/seguridad/2012/NI-MUH_05-2012.htm
Andrade S, Bartels DB, Lange R, Sandford L, Gurwitz J. Safety of metamizole: a systematic review of the literature. J Clin Pharm Ther.2016;41(5):459-77. https://doi.org/10.1111/jcpt.12422
Konijnenbelt-Peters J, van der Heijden C, Ekhart C, Bos J, Bruhn J, Kramers C. Metamizole (Dipyrone) as an Alternative Agent in Postoperative Analgesia in Patients with Contraindications for Nonsteroidal Anti-Inflammatory Drugs. Pain Pract. 2017;17(3):402-408. https://doi.org/10.1111/papr.12467
Marcén B, Sostres C, Lanas A. NSAID and gastrointestinal risk. Aten Primaria. 2016 Feb;48(2):73-6. https://doi.org/10.1016/j.aprim.2015.04.008
McCarberg BH, Cryer B. Evolving therapeutic strategies to improve nonsteroidal anti-inflammatory drug safety. Am J Ther. 2015;22(6):e167-78. https://doi.org/10.1097/MJT.0000000000000123
Lanas A, Benito P, Alonso J, Hernández-Cruz B, Barón-Esquivias G, Perez-Aísa A, et al. [Safe prescription recommendations for non steroidal anti-inflammatory drugs: Consensus document ellaborated by nominated experts of three scientific associations (SER-SEC-AEG)]. Gastroenterol Hepatol. 2014;37(3):107-27. https://doi.org/10.1016/j.gastrohep.2013.11.014
Wiffen PJ, Derry S, Moore R, Aldington D, Cole P, Rice AS C, Lunn MPT, Hamunen K, Haanpaa M, Kalso EA. Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews. Cochrane Database of Systematic Reviews. 2013 Nov 11;(11):CD010567. https://doi.org/10.1002/14651858.CD010567
Linde M, Mulleners WM, Chronicle EP, McCrory DC. Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults. Cochrane Database of Systematic Reviews. 2013 Jun 24;(6):CD010608. https://doi.org/10.1002/14651858.CD010608
Derry S, Cording M, Wiffen PJ, Law S, Phillips T, Moore R. Pregabalin for pain in fibromyalgia in adults. Cochrane Database of Systematic Reviews. 2016 Sep 29;9:CD011790. https://doi.org/10.1002/14651858.CD011790.pub2
National Institute for Health and Care Excellence. Neuropathic pain - pharmacological management. [Internet] NICE clinical guideline 173. Updated: February 2017. [Consultado 28 de febrero 2018] Disponible en: https://www.nice.org.uk/guidance/cg173/evidence/full-guidelinepdf-191621341
Sampson FC, Goodacre SW, O'Cathain A. Interventions to improve the management of pain in emergency departments: systematic review and narrative synthesis. Emerg Med J. 2014 Oct;31(e1):e9-e18. https://doi.org/10.1136/emermed-2013-203079
Abiuso N, Santelices J, Quezada R, Manejo del dolor agudo en el servicio de urgencia. Revista Médica Clínica Las Condes, 2017;28(2):248-60 https://doi.org/10.1016/j.rmclc.2017.04.012
Berde C, Walco G, Krane E, Anand K, Aranda J, Craig K, et al. Pediatric analgesic clinical trial designs, measures, and extrapolation: report of an FDA scientific workshop. Pediatrics. 2012;129(2):354-64. https://doi.org/10.1542/peds.2010-3591
Bonilla P, De Lima L, Díaz P, León M, González M. Uso de opioides en tratamiento del dolor. Manual para Latinoamérica, 2011. [Internet] Asociación Latinoamericana de Cuidados Paliativos, Sociedad Venezolana de Medicina Paliativa y Asociación Internacional de Hospicios Cuidados Paliativos (IAHPC). 2011. [Consultado 28 de febrero 2018]. Disponible en: http://cuidadospaliativos.org/uploads/2012/11/ManualOpioides.pdf
Alexander J, Manno M. Underuse of analgesia in very young pediatric patients with isolated painful injuries. Ann Emerg Med. 2003;41(5):617-22. https://doi.org/10.1067/mem.2003.138
Andersson V, Bergman S, Henoch I, Wickström Ene K, Otterström-Rydberg E, Simonsson H, et al. Pain and pain management in hospitalized patients before and after an intervention. Scand J Pain. 2017;15:22-29. https://doi.org/10.1016/j.sjpain.2016.11.006